Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunming Bangyu Pharmaceutical is a Chinese pharmaceutical company headquartered in Kunming, Yunnan Province, specializing in the development and manufacture of traditional Chinese medicines and chemical drugs. Founded in 1993, the company has established a significant market presence with its "Bangyu" brand, focusing primarily on pediatric and gynecological health. Its diverse product portfolio includes calcium supplements, zinc preparations, and treatments for respiratory and digestive conditions. The company operates modern, GMP-certified production facilities and is recognized as a high-tech enterprise within its region. Kunming Bangyu is dedicated to integrating traditional herbal knowledge with modern pharmaceutical technology to serve the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunming Bangyu Pharmaceutical.